Type 2 diabetes.
Conditions
Interventions
Intervention groups: first group: (training and placebo group) , second group: (training and supplement group ), third group: supplement group, fourth group: control group. The first group: received e
Sponsors
Razi university of Kermanshah
Eligibility
Sex/Gender
Female
Age
35 Years to 70 Years
Inclusion criteria
Inclusion criteria: Women with type 2 diabetes Not using Insulin and not having diabetes complications, including diabetic foot ulcers No history of any Cardiovascular, Kidney or Cancer disease in the last 5 years Lack of regular sports activity during the last six months Having a Health Certificate from a doctor to do sports activities
Exclusion criteria
Exclusion criteria: Inability to do resistance training Pregnancy or Breastfeeding Use of Drugs or Supplements (such as Corticosteroids and Anabolic hormones)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Biochemical markers of diabetic indicators. Timepoint: 48 hours before the start of the research (pre-test) and 48 hours after the last protocol implementation session (post-test). Method of measurement: Blood sampling and evaluation of samples by laboratory kits.;Biochemical markers of lipid profile. Timepoint: 48 hours before the start of the research (pre-test) and 48 hours after the last protocol implementation session (post-test). Method of measurement: Blood sampling and evaluation of samples by laboratory kits.;Biochemical markers of oxidative indices. Timepoint: 48 hours before the start of the research (pre-test) and 48 hours after the last protocol implementation session (post-test). Method of measurement: Blood sampling and evaluation of samples by laboratory kits.;Biochemical markers of liver indices. Timepoint: 48 hours before the start of the research (pre-test) and 48 hours after the last protocol implementation session (post-test). Method of measurement: Blood sampling and evaluation of samples by laboratory kits. | — |
Secondary
| Measure | Time frame |
|---|---|
| Height measurement. Timepoint: 48 hours before the start of the protocol. Method of measurement: Yagami model gauge made in Japan.;Weight measurement. Timepoint: 48 hours before the start of the protocol. Method of measurement: 1. Beurer digital scale, model PS07, made in Germany, with an accuracy of 0.1 kg.;Body composition measurement. Timepoint: 48 hours before the start of the protocol. Method of measurement: Zeus 9.9 plus body composition analyzer made in South Korea. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Lotfi
Razi University of Kermanshah
Outcome results
None listed